Shares of Methode Electronics, Inc (NYSE: MEI) fell sharply during Thursday’s session following weak quarterly earnings.
Methode Electronics posted adjusted earnings of 6 cents per share, missing market estimates of 12 cents per share. The company’s quarterly sales came in at $288.00 million versus expectations of $292.82 million, according to Benzinga Pro.
Methode Electronics shares fell 14.2% to $20.92 on Thursday.
Here are some other stocks moving in today's mid-day session.
Gainers
Save Foods, Inc. (NASDAQ: SVFD) shares climbed 186.7% to $6.16 after the company highlighted targeting of US carbon credit market following acquisition of majority ownership in newly- formed Nitrousink Ltd.
Cyngn Inc. (NASDAQ: CYN) gained 90.4% to $0.4643 after the company announced the issuance of a new patent, US-11,837,089-B2, for the autonomous vehicle (AV) and driving solutions.
Barnes & Noble Education, Inc. (NYSE: BNED) shares climbed 31.9% to $1.3850 following upbeat quarterly earnings.
Hempacco Co., Inc. (NASDAQ: HPCO) shares climbed 28.8% to $0.4331 after the company announced it entered into an exclusive Master Distribution Agreement with CBDAY Global. Under the agreement, CBDAY will exclusively sell Hempacco's line of hemp and CBD products in India and Thailand.
MicroAlgo Inc. (NASDAQ: MLGO) shares gained 26% to $12.07. MicroAlgo shares jumped over 295% on Wednesday after the company announced it plans to establish a postgraduate training practice base.
Kewaunee Scientific Corporation (NASDAQ: KEQU) climbed 25.5% to $22.53 following second-quarter earnings.
Inogen, Inc. (NASDAQ: INGN) climbed 23.3% to $6.15.
Satellogic Inc. (NASDAQ: SATL) rose 22% to $1.9584. Uzma and Satellogic signed a multi-million dollar +3-year agreement to advance geospatial capabilities in Southeast Asia.
Fitell Corporation (NASDAQ: FTEL) gained 19.7% to $1.70.
Altisource Asset Management Corporation(NYSE: AAMC) gained 19.3% to $4.0213. Altisource Asset Management reported key ruling in Blackrock and PIMCO litigation.
Semtech Corporation (NASDAQ: SMTC) climbed 18.5% to $19.80 after the company reported third-quarter financial results and issued guidance.
Altimmune, Inc. (NASDAQ: ALT) gained ...
Benzinga
